The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
|Slideshows|January 20, 2015
Best of Times in Liver Diseases
Author(s)Gregory W. Rutecki, MD
There has been an explosion of diagnostic and therapeutic discoveries affecting the liver. In this slide show: key points on 5 important clinically relevant areas.
Advertisement
There has been an explosion of diagnostic and therapeutic discoveries affecting the liver -- an essential organ, and common target of diseases seen in primary care. In this arena, it's the best of times.Leading a distinguished list of advances is the brave new world of interferon-free treatments for Hepatitis C.1I recently had the privilege of attending a “Liver Update”2 at the Cleveland Clinic. Here, I summarize 5 important areas that were-- and will continue to be -- clinically relevant.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Advertisement
Advertisement